Position in DNA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$155,477
-$181,243 QoQ
Shares Held
15,689
-71.4% QoQ
Ownership
0.023%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#94
of 183 holders
Holding Since
Mar 2022
12 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in DNA Over Time
Shares Held
Position Value (USD)
Derivatives in DNA
reported options exposure · as of Mar 31, 2024CallValue
$0
CallShares
0
PutValue
$93,380
PutShares
2,012
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Squarepoint Ops LLC holds $1,234,876,212 across 255 Biotechnology names. DNA ranks #215 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
198,567 | $123,814,467 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
1,191,732 | $88,760,199 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
233,999 | $70,440,718 | |
| 4 | INSM |
INSMED Inc
|
616,464 | $65,727,391 | |
| 5 | ARGX |
Argenx SE
|
58,400 | $54,181,768 | |
| 6 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
422,921 | $46,956,918 | |
| 7 | APGE |
Apogee Therapeutics, Inc.
|
290,713 | $38,586,336 | |
| 8 | AXSM |
Axsome Therapeutics, Inc.
|
154,605 | $37,842,665 |
All Filings in DNA
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $155,477 | 15,689 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $336,720 | 54,930 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,635,574 | 196,820 | Shares | Defined | 2026-02-13 | |
| 2025-03-31 | $670,770 | 117,679 | Shares | Defined | 2025-08-27 | |
| 2024-12-31 | $417,251 | 42,490 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $840,965 | 103,186 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $116,763 | 349,591 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $862,906 | 743,885 | Shares | Defined | 2024-05-15 | |
| 2024-03-31 | $93,380 | 80,500 | Put | Defined | 2024-05-15 | |
| 2023-12-31 | $25,681 | 15,196 | Shares | Defined | 2024-02-14 | |
| 2023-03-31 | $1,935,277 | 1,455,096 | Shares | Defined | 2023-05-15 | |
| 2022-06-30 | $218,717 | 91,898 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $258,097 | 64,044 | Shares | Defined | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||